Zdrowie i gospodarka · 16/05/2022

FDA Reclassifies HIV Diagnostic Tests from Class III to Class II Devices

The FDA is reclassifying certain HIV diagnostic tests from Class III to Class II devices, reducing regulatory burdens for manufacturers and allowing them to submit a 510(k) premarket notification instead of a premarket approval application (PMA)